Coloplast A/S
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLPBF research report →
Companywww.coloplast.com
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
- CEO
- Lars Soren Rasmussen
- IPO
- 2000
- Employees
- 16,741
- HQ
- Humlebæk, DK
Price Chart
Valuation
- Market Cap
- $12.83B
- P/E
- 44.08
- P/S
- 3.31
- P/B
- 7.23
- EV/EBITDA
- 10.22
- Div Yield
- 5.58%
Profitability
- Gross Margin
- 58.60%
- Op Margin
- 26.47%
- Net Margin
- 7.51%
- ROE
- 14.23%
- ROIC
- 10.58%
Growth & Income
- Revenue
- $27.82B · 2.93%
- Net Income
- $3.63B · -28.17%
- EPS
- $16.10 · -28.32%
- Op Income
- $7.57B
- FCF YoY
- 275.28%
Performance & Tape
- 52W High
- $100.00
- 52W Low
- $60.37
- 50D MA
- $65.98
- 200D MA
- $82.49
- Beta
- 0.50
- Avg Volume
- 651
Get TickerSpark's AI analysis on CLPBF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CLPBF Coverage
We haven't published any research on CLPBF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLPBF Report →